DHA-clozapine: Difference between revisions

Content deleted Content added

Inline

Revision as of 20:24, 12 December 2006

DHA-clozapine (trade name Clozaprexin) is an atypical antipsychotic that has been developed by Protarga. The drug has been created by the association of fatty acid docosahexaenoic acid (DHA) with clozapine. The advantages of this drug is that until the DHA and clozapine are not separated the drug is inactive, once it penetrate the blood brain barrier the DHA and clozapine are freed from each others slowly by enzymatic activity and more clozapine is liberated where it is needed randering the drug much more potent and longer active and requiring a much lower dosage and much fewer side effects. The drug is not yet available.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Revision as of 13:55, 22 July 2006 edit MarshBot (talk \| contribs) 50,214 edits Adding {{linkless}} template to orphan article ← Previous edit		Revision as of 20:24, 12 December 2006 edit undo SmackBot (talk \| contribs) 3,734,324 edits m Date/correct the maintenance tags using AWB Next edit →
Line 1:		Line 1:
	{{~~linkless-date~~\|July 2006}}		{{Orphan\|July 2006}}
	'''DHA-clozapine''' (trade name '''Clozaprexin''') is an atypical [[antipsychotic]] that has been developed by [[Protarga]]. The drug has been created by the association of fatty acid docosahexaenoic acid (DHA) with [[clozapine]]. The advantages of this drug is that until the DHA and clozapine are not separated the drug is inactive, once it penetrate the blood brain barrier the DHA and clozapine are freed from each others slowly by enzymatic activity and more clozapine is liberated where it is needed randering the drug much more potent and longer active and requiring a much lower dosage and much fewer side effects. The drug is not yet available.		'''DHA-clozapine''' (trade name '''Clozaprexin''') is an atypical [[antipsychotic]] that has been developed by [[Protarga]]. The drug has been created by the association of fatty acid docosahexaenoic acid (DHA) with [[clozapine]]. The advantages of this drug is that until the DHA and clozapine are not separated the drug is inactive, once it penetrate the blood brain barrier the DHA and clozapine are freed from each others slowly by enzymatic activity and more clozapine is liberated where it is needed randering the drug much more potent and longer active and requiring a much lower dosage and much fewer side effects. The drug is not yet available.